Hazlett, Burt & Watson’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3K Sell
103
-734
-88% -$17.8K ﹤0.01% 814
2026
Q1
$20K Buy
837
+7
+0.8% +$170 0.01% 587
2025
Q4
$20K Buy
830
+11
+1% +$267 0.01% 596
2025
Q3
$20K Buy
+819
New +$19.9K 0.01% 562

Other funds holding IBDS

Hazlett, Burt & Watson's IBDS Position: Q2 2026 in Review

Hazlett, Burt & Watson reduced its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 88% in Q2 2026, selling an estimated $17.8K and leaving 103 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #814.

Hazlett, Burt & Watson first reported a position in IBDS in Q3 2025 and has held it in 4 quarters since. The position peaked at $20K in Q1 2026. 415 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Hazlett, Burt & Watson held 103 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $3K as of Q2 2026.
  • Hazlett, Burt & Watson sold 734 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $17.8K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up ﹤0.01% of Hazlett, Burt & Watson's portfolio in Q2 2026, its #814 holding.
  • Hazlett, Burt & Watson first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q3 2025 and has held it in 4 quarters since.
  • Hazlett, Burt & Watson's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $20K in Q1 2026.
  • 415 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2026, filed 30 Jul 2026.